Pharma

The research project will be conducted using the Apple Watch and iPhone, and is set to begin during 2021.

The Cairo-based health tech startup’s founder revealed plans for the company’s expansion, with “an aggressive plan to cover MENA and Africa in the foreseeable future.”

The London-based company is backing a 300-person UPenn study comparing its digital therapeutic to the consumer wellness app.

This week's top stories include the vaccine distribution pipeline facing security risks as the UK begins administering the Pfizer COVID-19 vaccine, and Google rolling out an app that shows participants how their data is driving health insights.

The tool was designed to help patients and caregivers manage the condition and treatment. 

Yesterday at Bayer G4A summit a panel of startup execs came together to discuss the future of femtech and its role in improving research into women's health. 

The life science company created an initiative called the G4A Digital Health Partnership Program, which provides resources to both experienced and new digital health companies. 

Patients can digitally request a refill and answer questions about their condition, adherence and side effects.

Medidata said the deal will help better integrate clinical-grade metrics into its remote trial platform and broadly support the use of wearable sensors for clinical research.

The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors such as patient population recruitment and dropout rate.